Qlaris Bio
Latest round
- Series B
Last raised
- Apr 2024
Total raised
- $32M
Investors
- 5
About Qlaris Bio
Based in Massachusetts, US, and co-founded by Thurein Htoo (CEO) and Barbara Wirostko (CMO) in 2019, Qlaris Bio, Inc. operates as a biotechnology company that engages in developing topical therapeutic drugs. The clinical-stage biotech company’s product is QLS-111, a therapy designed to lower intraocular pressure (IOP) by targeting episcleral venous pressure (EVP). With a vasodilatory mechanism of action, QLS-111 has the potential to address critical unmet needs in conditions such as Normal Tension Glaucoma, Primary Open-Angle Glaucoma, Ocular Hypertension, and rare diseases like Sturge-Weber Syndrome.
Who invested in Qlaris Bio
5 investors across 2 rounds
See all investors in Qlaris Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qlaris Bio
Who invested in Qlaris Bio?
Qlaris Bio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qlaris Bio raised?
Qlaris Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Qlaris Bio last raise money?
Qlaris Bio's most recent round on record is a Series B, in Apr 2024.
What does Qlaris Bio do?
Based in Massachusetts, US, and co-founded by Thurein Htoo (CEO) and Barbara Wirostko (CMO) in 2019, Qlaris Bio, Inc.
Where is Qlaris Bio headquartered?
Qlaris Bio is headquartered in Dedham, US.
Which VCs invest in companies like Qlaris Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Qlaris Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Qlaris Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.